Handelsbanken Fonder’s ChemoCentryx, Inc. CCXI Stock Holding History

Handelsbanken Fonder’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,000	Closed	-$362K	–	1638
2022 Q3	$362K	Buy	+7,000	New	+$289K	﹤0.01%	1140
2022 Q1	–	Sell	-12,100	Closed	-$441K	–	1733
2021 Q4	$441K	Hold	12,100	–	–	﹤0.01%	1437
2021 Q3	$207K	Hold	12,100	–	–	﹤0.01%	1653
2021 Q2	$162K	Buy	12,100 +500	+4%	+$12.3K	﹤0.01%	1699
2021 Q1	$594K	Hold	11,600	–	–	﹤0.01%	1108
2020 Q4	$718K	Buy	11,600 +4,000	+53%	+$229K	﹤0.01%	975
2020 Q3	$416K	Hold	7,600	–	–	﹤0.01%	1086
2020 Q2	$437K	Buy	+7,600	New	+$414K	﹤0.01%	1024

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Handelsbanken Fonder's CCXI Position: Q4 2022 in Review

Handelsbanken Fonder sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 7,000 shares — an estimated $362K sold.

Handelsbanken Fonder first reported a position in CCXI in Q2 2020 and held it in 8 quarters. The position peaked at $718K in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Handelsbanken Fonder reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Handelsbanken Fonder sold 7,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $362K.
Handelsbanken Fonder first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 8 quarters.
Handelsbanken Fonder's ChemoCentryx, Inc. position peaked at $718K in Q4 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Handelsbanken Fonder's 13F filing for Q4 2022, filed 7 Feb 2023.